CMS published its proposed 2027 outpatient payment rule, including a 2.4% base rate increase alongside steep cuts to 340B drug payments and an expansion of site-neutral payment to off-campus imaging services. Provider groups warn that these changes would push many hospitals’ payments into negative territory. The post What to Know About CMS’ New Proposed Outpatient…
KFF estimates Medicare will spend $13.4 billion on the Medicare Advantage Quality Bonus Program in 2026 amid continued scrutiny of the program. The post Medicare to Spend $13B on MA Quality Bonus Program in 2026 appeared first on MedCity News.
PureTech Health spinout Celea Therapeutics will apply the financing toward a Phase 3 test of its idiopathic pulmonary (IPF) drug, deupirfenidone. The pivotal study will test the oral small molecule head-to-head against a standard of care IPF drug. The post Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug appeared first on MedCity…
States must rethink how program integrity is designed and delivered by focusing on four key priorities that enable oversight to scale alongside these programs. The post Modernizing Program Integrity in Medicaid Self-Directed Care appeared first on MedCity News.
As clinicians, we learn not to be agreeable, we learn to challenge and sit in discomfort. We ask the hard questions underneath the one being asked. That is the work these tools are not yet built to do. The post AI in Mental Health: Why Clinicians Need to Be in the Room appeared first on…
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage. The post When Evidence Gap Becomes a Commercial Liability appeared first on MedCity News.
KFF Health News senior correspondent Julie Appleby discussed the high cost of healthcare and the political fallout on WAMU’s 1A on June 30. Click here to hear Appleby on 1A. KFF Health News senior correspondent Renuka Rayasam discussed the public health concerns around a planned immigration detention center in Georgia on WUGA’s The Georgia Health…
By MIKE MAGEE When I asked my brilliant literary agent, Jill Kneerim, when I would know that my book proposal was ready for submission, she replied directly, “It will be ready when I say it is ready.” Eleven months later, in April, 2018, she finally green lit the project, and two weeks after that, in…
Aurenar’s V-Link, a non-invasive nerve stimulation device for preventing brain hemorrhage complications, just won FDA breakthrough device designation after early trials showed it cut cerebral vasospasm by more than 40%. The post This Ear-Based Device Could Save Patients from Brain Bleed Complications appeared first on MedCity News.